| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vi Non-segmental Vitiligo | Phase 2 | 2024-06-04 |
| Completed | Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis Atopic Dermatitis | Phase 1 / Phase 2 | 2021-10-13 |
| Completed | A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. Acne Vulgaris | Phase 2 | 2019-09-18 |
| Completed | Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknow Pruritus | Phase 2 | 2019-01-22 |
| Completed | A Study Comparing Two Topicals in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 1 | 2018-11-20 |
| Completed | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurig Pruritus, Prurigo Nodularis | Phase 3 | 2018-08-29 |
| Completed | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurig Pruritus, Prurigo Nodularis | Phase 3 | 2018-05-02 |
| Terminated | Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) Pruritus, Prurigo Nodularis, Atopic Dermatitis | Phase 3 | 2018-03-15 |
| Completed | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Pruritus, Psoriasis | Phase 2 | 2017-11-01 |
| Completed | Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough Refractory Chronic Cough | Phase 2 | 2017-10-03 |
| Completed | A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to S Papulopustular Rosacea | Phase 3 | 2017-09-05 |
| Completed | A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-t Acne Vulgaris | Phase 3 | 2017-07-17 |
| Completed | A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment Facial Papulopustular Rosacea | Phase 3 | 2017-06-02 |
| Completed | A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment Facial Papulopustular Rosacea | Phase 3 | 2017-06-01 |
| Terminated | Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury Pruritus, Burns | Phase 2 | 2016-11-01 |
| Completed | Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis Pruritus, Atopic Dermatitis | Phase 2 | 2016-11-01 |
| Completed | Dermal Photo Allergic Skin Reaction Healthy | Phase 1 | 2016-09-21 |
| Completed | A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Healthy | Phase 1 | 2016-09-08 |
| Completed | Dermal Cumulative Irritant Patch Study Healthy | Phase 1 | 2016-09-01 |
| Completed | Dermal Phototoxicity Study Healthy | Phase 1 | 2016-08-17 |
| Completed | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-S Acne Vulgaris | Phase 3 | 2016-05-01 |
| Completed | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-S Acne Vulgaris | Phase 3 | 2016-05-01 |
| Completed | Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea Rosacea, Papulopustular Rosacea | Phase 2 | 2015-09-01 |
| Completed | Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cance Rash Due to Epidermal Growth Factor Receptor Inhibitors | Phase 2 | 2014-10-01 |
| Completed | A Pharmacokinetic Study of Minocycline in Male and Female Volunteers Acne | Phase 1 | 2014-09-01 |
| Completed | A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodula Prurigo Nodularis | Phase 2 | 2014-07-09 |
| Completed | VPD-737 for Treatment of Chronic Pruritus Chronic Pruritus | Phase 2 | 2013-10-15 |
| Completed | Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Acne Vulgaris | Phase 2 | 2012-01-01 |
| Completed | Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients Impetigo | Phase 2 | 2010-08-01 |
| Terminated | Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients Rosacea | Phase 2 | 2010-06-01 |
| Terminated | A Study of MK0594 in Patients With Alcohol Dependence (0594-020) Alcohol Dependence | Phase 2 | 2009-02-27 |
| Completed | Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003) Urinary Incontinence, Overactive Bladder | Phase 2 | 2006-02-21 |